SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

The shifting medical practice may decrease access to care More patients insured but doctors are at full capacity

The father of classic dermatology This month we feature Ferdinand Ritter von Hebra

MEDICA 2014: robotics in the cardiology field Events highlight new advances

Double-jeopardy: multiple medical conditions investigated A new report looks into holistic approach when addressing cardiovascular issues

Toshiba and Johns Hopkins join forces over big data Leveraging big data to improve outcomes

New MR technique offers new insight into multiple sclerosis May help improve treatment monitoring

Is it time to be anti-antibiotics? The cost of over-prescribed antibiotics goes far beyond funds

MEDICA 2014: new imaging technology improves breast cancer diagnosis Shows structures that mammo can't

Iodine-based contrast for CT safe for most patients Goes against the previous notion

September's New Product Showcase This month's roundup of the latest industry products.

Courtesy of IBA

CMS won't budge on proton therapy cuts

by Loren Bonner , DOTmed News Online Editor
Medicare reimbursement rates for proton therapy included in the final Hospital Outpatient Prospective Payment System (HOPPS) rule for 2013 reflect significant reductions from 2012.

Specifically, the code for ambulatory surgical center payment systems (APC) in the HOPPS rule that applies to proton treatment "complex" procedures — harder to treat procedures — decreases the mean payment for proton therapy from $1,549 in 2012 down to $682 for 2013.

Story Continues Below Advertisement

Ultrasound Field Service

We specialize in FDA compliant and ACR certified diagnostic imaging service nationwide. We deliver world-class emergency repair and world-class service on your ultrasound medical devices. Call 866-310-0071



According to the Advisory Board Company, a global research and consulting firm, this translates into a 32 percent decrease in revenues from an average of $35,917 per patient in 2012 to a projected average of $24,565 per patient for 2013.

All other radiation therapy techniques, like stereotactic body radiosurgery (SBRT) and intensity modulated radiation therapy (IMRT), will be reimbursed only slightly lower than in 2012, according to the new rule for 2013.

The Centers for Medicare and Medicaid Services released the proposed rule this summer. During the comment period, stakeholders argued that the decrease in the cost of proton therapy was due to flawed and incorrect data by one hospital during 2010 and 2011. The University of Pennsylvania's proton therapy center owned up to the mistake and tried to get CMS to fix the data. However, the agency decided not to take that into account for 2013, and stuck by what it originally proposed.

On Nov. 7, the American College of Radiology submitted comments to CMS about the final rule, urging them not to go forward with the proposed cuts for 2013, "due to the concern that some of the data used in CMS' analysis was not representative of proton beam therapy's true costs," stated the letter.

Leonard Arzt, executive director of the National Association for Proton Therapy, said any reimbursement reductions either by Medicare or private insurers could have serious future implications for cancer patients seeking and demanding proton therapy.

CMS published the final rule on Nov. 15.

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED